We observed a clear trend for patients with NHL to be at higher risk of neutropenic complications than their breast cancer counterparts (very probably due to more intensive chemotherapy regimens).
← all excerpts
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
1
—
—